[1] |
Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity among adults: United States, 2011-2012[J]. NCHS Data Brief, 2013(131):1-8.
|
[2] |
Ward ZJ, Long MW, Resch SC, et al. Redrawing the US obesity landscape: bias-corrected estimates of state-specific adult obesity prevalence[J]. PLoS One, 2016, 11(3): e0150735.
|
[3] |
Moss BG, Yeaton WH. Young children's weight trajectories and associated riskfactors: results from the Early Childhood Longitudinal Study-Birth Cohort[J]. Am J Health Promot, 2011, 25(3):190-198.
|
[4] |
Zaydfudim V, Feurer ID, Moore DE, et al. The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation[J]. Surgery, 2009, 146(2):174-180.
|
[5] |
Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States[J]. Hepatology, 2002, 35(1):105-109.
|
[6] |
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States[J]. Gastroenterology, 2011, 141(4):1249-1253.
|
[7] |
Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J]. Gastroenterology, 2015, 148(3):547-555.
|
[8] |
Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis[J]. J Clin Gastroenterol, 2006, 40 Suppl 1:S11-16.
|
[9] |
Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation[J]. Liver Transpl, 2012, 18(10): 1147-1153.
|
[10] |
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation[J]. Am J Transplant, 2004, 4(5):686-693.
|
[11] |
Saab S, Cho D, Lassman RC, et al. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient[J].J Hepatol, 2005, 42(1):148-149.
|
[12] |
Lim LG, Cheng CL, Wee A, et al. Prevalence and clinical associations of posttransplant fatty liver disease[J]. Liver Transpl, 2007, 27(1):76-80.
|
[13] |
Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events[J]. Liver Transpl, 2011, 17(1):15-22.
|
[14] |
McAlister VC, Haddad E, Renouf E, et al. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis[J]. Am J Transplant, 2006, 6(7):1578-1585.
|
[15] |
Dumortier J, Giostra E, Belbouab S, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil"[J]. Am J Gastroenterol, 2010, 105(3):613-620.
|
[16] |
Perkins JD. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation[J]. Liver Transpl, 2006, 12(6):1012-1013.
|
[17] |
Ayloo S, Armstrong J, Hurton S, et al. Obesity and liver transplantation[J]. World J Transplant, 2015, 5(3):95-101.
|
[18] |
中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011, 27(9):711-717.
|
[19] |
Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates[J]. Surg Obes Relat Dis, 2013, 9(5):653-658.
|
[20] |
Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation[J]. Surg Obes Relat Dis, 2008, 4(2):159-164.
|
[21] |
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease[J]. Am J Transplant, 2013, 13(2):363-368.
|
[22] |
Zamora-Valdes D, Watt KD, Kellogg TA, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy[J]. Hepatology, 2018, 68(2):485-495.
|
[23] |
Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation[J]. Obes Surg, 2007, 17(11):1517-1519.
|
[24] |
Suraweera D, Dutson E, Saab S. Liver transplantation and bariatric surgery: best approach[J]. Clin Liver Dis, 2017, 21(2):215-230.
|
[25] |
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation[J]. Surg Endosc, 2013, 27(1):81-85.
|
[26] |
Osseis M, Lazzati A, Salloum C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes[J]. Obes Surg, 2018, 28(1): 242-248.
|
[27] |
Toolabi K, Golzarand M, Farid R. Laparoscopic adjustable gastric banding: efficacy and consequences over a 13-year period[J]. Am J Surg, 2016, 212(1):62-68.
|
[28] |
Vu L, Switzer NJ, De Gara C, et al. Surgical interventions for obesity and metabolic disease[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(2):239-246.
|
[29] |
Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity[J]. Cochrane Database Syst Rev, 2009(2):CD003641.
|
[30] |
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study[J]. Ann Surg, 2008, 247(3):401-407.
|
[31] |
Moshiri M, Osman S, Robinson TJ, et al. Evolution of bariatric surgery:a historical perspective[J]. AJR Am J Roentgenol, 2013, 201(1):W40-48.
|
[32] |
Tavakol MM, Amirkiai S, Amin R, et al. Laparoscopic sleeve gastrectomy (LSG) is safe, well tolerated and improves candidacy in morbidly obese patients awaiting liver transplantation[J]. Transplantation, 2012, 94 Suppl:226.
|
[33] |
Campsen J, Zimmerman M, Shoen J, et al. Adiustable gastric banding in a morbidly obese patient during liver transplantation[J]. Obes Surg, 2008, 18(12):1625-1627.
|
[34] |
Guerrero Pérez F, Pia Marengo A, Fabregat J, et al. Combined sleeve gastrectomy and orthotopic liver transplantation in patient with type 2 obesity and advanced liver disease[J]. Endocrinol Diabates Nutr, 2017, 64(5):282-284.
|
[35] |
Kumar S, Khandelwal N, Kumar A, et al. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-first report from India[J]. Indian J Gastroenterol, 2017, 36(3):243-247.
|
[36] |
Nesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity?[J]. Obes Surg, 2017, 27(5):1387-1390.
|
[37] |
Tariciotti L, D'Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: first European case-report[J]. Int J Surg Case Rep, 2016(28):38-41.
|
[38] |
Elli EF, Masrur MA, Giulianotti PC. Robotic sleeve gastrectomy after liver transplantation[J]. Surg Obes Relat Dis, 2013, 9(1):e20-22.
|
[39] |
Pajecki D, Cesconetto DM, Macacari R, et al. Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report[J]. Arq Bras Cir Dig, 2014, 27 Suppl 1:81-83.
|
[40] |
Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation[J]. Liver Transpl, 2013, 19(12):1324-1329.
|
[41] |
Lainas P, Dupond-Athenor A, Tranchart H, et al. Safety and feasibility of single-port sleeve gastrectomy following liver transplantation[J]. Obes Surg, 2018, 28(3):874-876.
|
[42] |
Yemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression[J]. Am J Transplant, 2018, 18(11):2772-2780.
|
[43] |
Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity[J]. Transplantation, 2001, 72(1):156-159.
|